Follow us on
Welcome Guest! You are here: Home » Health
Long-acting insulin more effective for type 1 diabetes
Sunday October 5, 2014 9:15 AM, IANS

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type 1 diabetes, reveals a new study.

Researchers looked at once daily and twice daily doses of both long- and intermediate-acting insulin and ranked their effectiveness, safety and cost-effectiveness.

"In patients with type 1 diabetes, we found that long-acting insulin is superior to intermediate-acting insulin when it came to controlling blood sugar, preventing weight gain and treating severe hypoglycemia," said Andrea Tricco, lead author and assistant professor at the University of Toronto's Dalla Lana School of Public Health in Canada.

For their study, Tricco and her colleagues used data from 39 studies and compared two long-acting forms of insulin - glargine and detemir - against intermediate-acting forms, like Neutral Protamine Hagedorn (NPH).

They found that long-acting insulin takes about one hour after ingesting to begin lowering blood sugar and lasts up to 26 hours whereas intermediate-acting insulin takes between one and three hours to begin lowering blood sugar and can last up to 16 hours.

"Also those taking intermediate-acting insulin were more likely to gain weight - an average of four to six pounds more than the participants who took long-acting insulin doses," explained Tricco.

The researchers also found that people with type 1 diabetes were 38 percent less likely to experience severe hypoglycemia or extremely low blood sugar.

"With this information, patients and their doctors should tailor their choice of insulin according to preference, cost and accessibility," concluded Tricco.

The study appeared in the journal BMJ.




Share this page
 Comments
Note: By posting your comments here you agree to the terms and conditions of www.ummid.com
comments powered by Disqus
Advertisement
| Quick links
About ummid.com
Contact us
Feedback
Subscribe to: RSS » Facebook » Twitter » Newsletter
Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange
Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.
© 2012 Awaz Multimedia & Publications. All rights reserved.